Indian Pulmonary Arterial Hypertension Drugs Market Analysis


  • Type: Common Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: India
  • Report ID : 1391

  • Format: PPT, PDF

Indian Pulmonary Arterial Hypertension Drugs Market: Segmented By Drug Class (Soluble Guanylate Cyclase (SGC) Stimulators, Prostacyclin and Prostacyclin Analogs, Phosphodiesterase 5 (PDE-5), and Endothelin Receptor Antagonists (ERA)), By Route of Administration (Oral, Inhaled, Intravenous, and Subcutaneous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 1391 Categories: ,

Report Overview

Indian Pulmonary Artery Hypertension (PAH) Drugs Market size was valued at USD XX billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of XX% from 2019 to 2028.

Pulmonary Arterial Hypertension (PAH) is one of the rare diseases, which usually affects the pulmonary arteries. High blood pressure in the lungs is called pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). It is characterized by narrowed and blocked arteries and capillaries. This rare disease can grow worse over the period and may result to death if left untreated. The symptoms of pulmonary arterial hypertension include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting. The increase in the number of geriatrics leads to consequences which is several cases includes complications related to pulmonary arterial hypertensions. The technological advancements are also steadily focusing on the identification of new molecular pathways which contributes to development of better treatments possible over the forecast period.

Market Drivers

The increasing prevalence of cardiovascular and pulmonary disorders is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population that is more susceptible to such medical ailments is providing a boost to the market growth.
Besides this, changes in lifestyles, such as excessive alcohol consumption, a lack of physical activity, and unhealthy dietary patterns, have enhanced the risks of hypertension and high blood pressure. This, along with the development of novel orphan drugs and technologically advanced devices for the treatment of PAH, is favoring the market growth.
Other factors, including increasing awareness among the masses regarding the available treatment alternatives for PAH, and improving healthcare infrastructure across the nation, are expected to drive the market further.

1. Indian Pulmonary Arterial Hypertension Drugs Market Overview…………
A. Market Size
2. Market Growth Drivers …………………………………………………………………
A. Increasing Prevalence of Cardiovascular & Pulmonary Disorders
B. Rising Geriatric Population
C. Adoption of Technologically Advanced Products
3. Major Causes of Pulmonary Arterial Hypertension………………………
A. Congestive Heart Failure
B. Heart Failure
C. Blood Clots in the Lungs
D. Liver Disease
E. Sleep Apnea
4. Pulmonary Arterial Hypertension Drugs Market Segmentation……………
A. By Drugs Class
I. Soluble Guanylate Cyclase (SGC) Stimulators
II. Prostacyclin and Prostacyclin Analogs
III. Phosphodiesterase 5 (PDE-5)
IV. Endothelin Receptor Antagonists (ERA)
B. By Route of Administration
I. Oral
II. Inhaled
III. Intravenous
IV. Subcutaneous
C. By Distribution Channel
I. Hospital Pharmacy
II. Retail Pharmacy
III. Online Pharmacy
5. Pulmonary Arterial Hypertension Drugs Market Major Products Market Share..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………
A. Merck & Co. overview, Product & Services, Strategies & Financials
B. Novartis International AG overview, Product & Services, Strategies & Financials
C. Pfizer Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Pulmonary Arterial Hypertension Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drugs Class:

On the basis of drug class, the pulmonary arterial hypertension (PAH) drugs market has been segmented into Soluble Guanylate Cyclase (SGC) stimulators, prostacyclin and prostacyclin analogs, phosphodiesterase 5 (PDE-5), and Endothelin Receptor Antagonists (ERA). ERA and prostacyclin and prostacyclin analogs for treating PAH accounted for a significant market share in 2019. Opsumit and Tracleer target ETB and ETA receptors, whereas Volibris/Letairis targets the ETA receptor.

By Route of Administration:

Based on the route of administration, the pulmonary arterial hypertension (PAH) market is segmented into oral, inhaled, intravenous, and subcutaneous.

By Distribution Channel:

Based on the distribution channel, the pulmonary arterial hypertension (PAH) market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Major Player

The leading players in the Indian market for Pulmonary Arterial Hypertension drugs are Arena Pharmaceuticals, Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline Plc, Johnson & Johnson (Actelion Pharmaceuticals, Ltd.), Merck & Co. Inc., Novartis International AG, Pfizer.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements